Percutaneous Coronary Intervention
Patients with prior PCI have a lower mortality rate than those without prior PCI
Published in Clinical Trials Week, June 27th, 2005
According to researchers in Canada, "We sought to characterize the outcomes of patients with a prior percutaneous coronary intervention (PCI) who presented with a non-ST-segment elevation acute coronary syndrome (ACS). We analyzed the 30 and 180 day outcomes of 3012 patients with prior PCI and 21,154 patients without prior PCI enrolled in three randomized ACS trials (GUSTO IIb, PURSUIT, and PARAGON-B)."
M. Labinaz and colleagues of the University of Ottawa explained, "The median (25th, 75th percentile) interval between...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2005-06-27)
More Articles from Clinical Trials Week
- Interferon
Peginterferon alfa-2b plus ribavirin treatment evaluated in children with HPC - Non-Small Cell Lung Cancer
Celecoxib can be safely used concurrently with thoracic radiotherapy - Prostate Cancer
Combining recombinant cancer vaccine with radiotherapy is a safe regimen - Psoriatic Arthritis
Addition of cyclosporin to methotrexate treatment has limited effects - Acute Radiation Syndrome
New drug being developed for the treatment of acute radiation syndrome - Addiction Medicine
Harold Urschel to investigate protocols for treating methamphetamine dependence - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
